Secondary Hyperparathyroidism Clinical Trials

130 clinical trials for Secondary Hyperparathyroidism across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Precision Medicine Approaches to Renal Osteodystrophy — RECRUITING
• Parathyroid Tumor Clonal Status — RECRUITING
• A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis — RECRUITING · PHASE3
• A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis — RECRUITING · PHASE3
• A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj. — RECRUITING
• A MULTICENTER, MULTIPLE-DOSE, TWO-ARM, ACTIVE-CONTROLLED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO COMPARE THE THERAPEUTIC EFFICACY AND SAFETY OF ORAL DOSES OF CINACALCET HCL WITH INTRAVENOUS DOSES OF AMG 416 IN HEMODIALYSIS SUBJECTS WITH SECONDARY HYPERPARATHYROIDISM — RECRUITING
• The IMPACT SHPT Study: Study to Evaluate the Improved Management of iPTH with Paricalcitol-centered Therapy vs. Cinacalcet Therapy with Low-dose Vitamin D in Hemodialysis Patients with Secondary Hyperparathyroidism — COMPLETED · PHASE4
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) — TERMINATED · PHASE3
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants — NOT_YET_RECRUITING · PHASE2
• A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism — COMPLETED · PHASE1
• The Trial of SHR6508 in Secondary Hyperparathyroidism — COMPLETED · PHASE3
• Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1 — COMPLETED · PHASE3
• Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 — COMPLETED · PHASE3
• Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism — TERMINATED · PHASE3
• Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients — TERMINATED · PHASE1
• LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients — COMPLETED · PHASE1
• Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism — ACTIVE_NOT_RECRUITING
• A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis — COMPLETED · PHASE2
• Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial (ActiVitD) — TERMINATED · PHASE4
• Intraoperative Parathyroid Hormone Monitoring to Guide Surgery in Renal hyperparathyroIdism — NOT_YET_RECRUITING · NA
• The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD — OTHER · PHASE2
• Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure — OTHER
• Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients — COMPLETED
• Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism — COMPLETED
• Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol — TERMINATED · PHASE4
• Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCT — COMPLETED
• A Trial of SHR6508 in Secondary Hyperparathyroidism — COMPLETED · PHASE1
• A Study of SHR6508 in Secondary Hyperparathyroidism — OTHER · PHASE2
• FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease — COMPLETED · NA
• Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). — COMPLETED · PHASE3
• E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events — COMPLETED · PHASE3
• Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia — COMPLETED · PHASE3
• Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism — COMPLETED · NA
• A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism — OTHER · PHASE3
• Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients — COMPLETED · PHASE4
• Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease — COMPLETED
• Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) — COMPLETED · PHASE3
• IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism — COMPLETED
• Pediatric Chronic Kidney Disease Safety and Efficacy — TERMINATED · PHASE3
• The Longitudinal PTH-Study — COMPLETED
• Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease — COMPLETED · PHASE1
• Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients — COMPLETED · PHASE4
• SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis — COMPLETED · PHASE3
• Phase 3 Study of SK-1403 — COMPLETED · PHASE3
• A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 — COMPLETED · PHASE1
• Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects — COMPLETED · PHASE1
• Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet — COMPLETED · PHASE3
• Dose Adjustment Trial of SK-1403 in Hemodialysis Patients With Secondary Hyperparathyroidism — COMPLETED · PHASE2
• Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity — COMPLETED · PHASE4
• 20070360 Incident Dialysis — COMPLETED · PHASE4

Refine this search